Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
about
Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences.(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areasElevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography studyQuantitative analysis and comparison study of [18F]AlF-NOTA-PRGD2, [18F]FPPRGD2 and [68Ga]Ga-NOTA-PRGD2 using a reference tissue modelHistidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and micePrenatal stress induces increased striatal dopamine transporter binding in adult nonhuman primatesModeling of PET data in CNS drug discovery and development.Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleusMulti-graphical analysis of dynamic PET.Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humansPET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility.Empirical Bayesian estimation in graphical analysis: a voxel-based approach for the determination of the volume of distribution in PET studies.Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine.Improving PET receptor binding estimates from Logan plots using principal component analysisEvaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.No differential regulation of dopamine transporter (DAT) and vesicular monoamine transporter 2 (VMAT2) binding in a primate model of Parkinson disease.Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease.Improved kinetic analysis of dynamic PET data with optimized HYPR-LRParametric Imaging and Test-Retest Variability of ¹¹C-(+)-PHNO Binding to D₂/D₃ Dopamine Receptors in Humans on the High-Resolution Research Tomograph PET ScannerCannabinoid type 1 receptor availability in the amygdala mediates threat processing in trauma survivors.An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of (11)C-LY2459989.Kinetic Analysis and Quantification of [¹¹C]Martinostat for in Vivo HDAC Imaging of the Brain.Evaluation of the sensitivity of the novel α4β2* nicotinic acetylcholine receptor PET radioligand 18F-(-)-NCFHEB to increases in synaptic acetylcholine levels in rhesus monkeys.The dopamine transporter is decreased in the striatum of subjects with restless legs syndromeThe use of alternative forms of graphical analysis to balance bias and precision in PET images.Voxelwise quantification of [(11)C](R)-rolipram PET data: a comparison between model-based and data-driven methods.Kinetic modeling of (11)C-LY2795050, a novel antagonist radiotracer for PET imaging of the kappa opioid receptor in humans.Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis.Tomography of epidermal growth factor receptor binding to fluorescent Affibody in vivo studied with magnetic resonance guided fluorescence recovery in varying orthotopic glioma sizes.Imaging of alcohol-induced dopamine release in rats:preliminary findings with [(11) C]raclopride PETQuantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography.Evaluation of [(18)F]-(-)-norchlorofluorohomoepibatidine ([(18)F]-(-)-NCFHEB) as a PET radioligand to image the nicotinic acetylcholine receptors in non-human primates.18F-fallypride binding potential in patients with schizophrenia compared to healthy controlsMultiple linear analysis methods for the quantification of irreversibly binding radiotracers.GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding.Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependenceClustering-initiated factor analysis application for tissue classification in dynamic brain positron emission tomography.Quantification of blood flow-dependent component in estimates of beta-amyloid load obtained using quasi-steady-state standardized uptake value ratio.Comparative assessment of parametric neuroreceptor mapping approaches based on the simplified reference tissue model using [¹¹C]ABP688 PET.
P2860
Q27321190-E5E89736-43B4-4E42-BE6B-4980D0794E62Q28259782-0E5DD985-EF1A-4561-A4C8-88E21F6F81B6Q28290553-F43D3CFC-B13E-4E08-8E7E-FE2D043A6EEFQ28729872-81C6D361-B36A-48A1-8999-F351F1BF7BF0Q30421144-54FFFBDF-ABB9-4953-B678-2BE7A00E5538Q30429526-D96A7B0A-602D-4C07-B843-16D797E77D1BQ30623699-9E72DCAB-6473-4F07-B3AF-977B6D883E63Q33634418-4B4B8128-6675-4036-B51D-2EC704CE48D2Q33668796-77F77FC7-BF8B-4655-9ED1-E97BA50E4420Q33786437-7B072651-979D-4255-9B74-A3D1C1CB08F4Q33925457-321296F6-A9ED-4A2C-97D4-8DCC45C0FBA8Q33958124-60BCCE52-1EDD-494B-8D1C-A61003BA312BQ33993075-0EFDD018-9777-4AA1-A8C6-19D506038DEEQ34002723-652E1427-5F99-4D5D-9687-D8D340A676CBQ34022056-0DB4DB6E-CD7D-4D3F-9419-0D109E4FDEF8Q34073200-D5E1079D-76C5-440E-8AE7-04B6CC14CACEQ34168229-BB379D3D-C12D-4CE4-8C89-5371759BE453Q34313058-CDBC3B20-CE07-43DE-BECC-583B466B8D3AQ34324345-DDBD8FD6-CA7D-432D-8FED-62B3A3800EAEQ34362666-50AD2B62-C2BE-4F17-ABCD-26BA170B0069Q34393055-FF1ED577-FA4A-4026-84EE-29C775E975FBQ34421107-722BC31D-635B-4BD3-ACC5-D0EAB3104C7AQ34467002-4D23FC65-D30A-4B27-9278-3A6CECF6A38EQ34472238-8A5D49A3-0EE9-4D2D-81B3-DCABEE09C728Q34585898-C5D2B9D5-C518-43E3-8B7E-612584B3F058Q34627591-4A182655-52F6-4667-A894-3E0B6D1377F4Q34628071-85EB8111-C7FB-457E-AA14-A09DF922EA57Q34727498-3E69E7D4-947B-4E28-8238-DD264C7F7453Q34765568-27C340D9-2161-4176-8237-2F55882AE1CAQ35049632-241ADA17-52F0-44B6-8DEC-1B3EDFAA3209Q35089565-2B0BE666-5C4B-4F9F-ABC7-937232DA37F7Q35208026-DD0E7179-7B64-47A7-82F1-B707CD50EF97Q35637965-9C89391E-960C-4ED4-94E6-5090E63168A2Q35752862-8B8ED659-CF54-48D7-97F9-6AC35D2DFA55Q35945042-C1F226CC-AA67-4374-BCAE-1B85FE806622Q35983900-1D1A2F98-38B2-4E11-8511-2D6D1F06E0D7Q36162168-B89380C5-E5CC-4F46-B493-6841B6A34E4BQ36267283-253CD279-306D-42BC-A635-A790E236D557Q36267484-D2A01B70-18C2-41CD-844C-B78FD47319F5Q36350532-2EDA1390-9BDF-4CB9-A6BE-DAA99CF10645
P2860
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@en
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@nl
type
label
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@en
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@nl
prefLabel
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@en
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@nl
P2093
P2860
P1476
Strategies to improve neuroreceptor parameter estimation by linear regression analysis.
@en
P2093
Hiroshi Toyama
Masanori Ichise
Richard E Carson
Robert B Innis
P2860
P304
P356
10.1097/00004647-200210000-00015
P577
2002-10-01T00:00:00Z